Amsterdam, June 6, 2016 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that it has been chosen as the new publisher of the Journal of Ayurveda and Integrative Medicine (J-AIM), the official publication of the World Ayurveda Foundation and Trans-Disciplinary University, Bangalore. Elsevier will publish J-AIM from volume 7 onwards.
J-AIM is an international open access journal supported by the World Ayurveda Foundation (WAF) and Transdisciplinary University (TDU), Bangalore. The journal is a trans-disciplinary platform for integrative health sciences and aims to explore the relationships between Ayurveda, traditional medicine, biomedicine and other contemporary health sciences, encouraging meaningful collaboration to promote effective, safe and affordable global health.
J-AIM's Editor-in-Chief, Dr. Bhushan Patwardhan, has over 20 years' experience in academic and education governance. Currently Professor at the Interdisciplinary School of Health Sciences, University of Pune, Dr. Patwardhan has authored more than 100 research publications and has a Scopus H-index of 24.
J-AIM is ranked as the 3rd top integrative medicine journal in India and is indexed in DOAJ, Scopus and PubMed; all journal issues will be published online on ScienceDirect.
"The World Ayurveda Foundation (WAF), with its global stakeholders, is proud to work together with TDU and Elsevier to publish J-AIM," commented A Jayakumar, Secretary General, WAF. "We believe the global Ayurveda community already benefit and will continue to respect and appreciate the quality of publication standards of J-AIM."
"The university remains as excited about publishing J-AIM today as it was six years ago when J-AIM was launched," said Darshan Shankar, Vice Chancellor, TDU. "We believe J-AIM is an effective knowledge platform to modernize of India's medical heritage. Working with Elsevier to publish the journal is a significant milestone for J-AIM given the reputation Elsevier enjoys as a global leader in quality publishing."
"It is with pleasure that we announce our publishing agreement with TDU and WAF to publish J-AIM ," commented Surya Nedunchezhiyan, Publisher at Elsevier. "Elsevier continually strives to meet the needs and interest of our readers and to disseminate cutting-edge research in all scientific fields and we are confident that our publishing standards will meet J-AIM's goals."
For more information or to submit a paper, go to: journals.elsevier.com/journal-of-ayurveda-and-integrative-medicine.
About the World Ayurveda Foundation
The World Ayurveda Foundation (WAF) is an initiative by Vijnana Bharati that aims to promote Ayurveda globally. It is a platform that supports research, health-care programs, documentation, and other knowledge initiatives related to Ayurveda. http://www.ayurworld.org
About the Institute of Trans-disciplinary Health Sciences and Technology
The Institute of Trans-disciplinary Health Sciences and Technology (TDU) is an innovation oriented autonomous State Private University. The University is founded by the Foundation for Revitalization of Local Health Traditions (FRLHT) Trust and has evolved from 22 years of FRLHT's pioneering work. The scope of trans-disciplinary studies includes Indian traditional health sciences, Biomedicine, Life sciences, Social sciences, Environmental studies, Design & Architecture, Performing and Fine arts, Engineering and Management. TDU focuses on research and education and most importantly, the translation of knowledge for societal change. tdu.edu.in
About open access publishing at Elsevier
Elsevier has been providing open access publishing options since 2005. Today, researchers can choose to publish open access in over 1,600 established peer-reviewed journals as well as over 500 open access journals and these numbers will continue to grow rapidly. All of Elsevier's open access publications have been peer reviewed, ensuring that the broader community not only reads the latest research but that it is factual, original and of the highest quality and ethical standards. For more information about Elsevier's open access program, visit http://www.elsevier.com/openaccess.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions -- among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey -- and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. http://www.elsevier.com
+31 20 485 2463